---
title: "Jacobio Pharmaceuticals files HKEX next-day return disclosing share buyback at HKD 4.64-4.66"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293035499.md"
description: "Jacobio Pharmaceuticals filed a next-day return with the HKEX disclosing that it repurchased 105,000 ordinary shares for treasury on July 17, 2026. The shares were bought at prices ranging from HKD 4.64 to 4.66 each, totaling HKD 487,764. No shares were cancelled in this transaction."
datetime: "2026-07-17T12:19:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293035499.md)
  - [en](https://longbridge.com/en/news/293035499.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293035499.md)
generator: "portal-rs"
---

# Jacobio Pharmaceuticals files HKEX next-day return disclosing share buyback at HKD 4.64-4.66

-   Jacobio Pharmaceuticals repurchased 105,000 ordinary shares on July 17, 2026 for treasury, HKD 4.64–4.66 each; aggregate HKD 487,764. \* Total repurchased shares: 105,000. Total cancelled shares: 0. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248610), on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01167.HK](https://longbridge.com/en/quote/01167.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)

## Related News & Research

- [Jacobio Pharmaceuticals Sets Board Meeting to Approve Interim 2026 Results](https://longbridge.com/en/news/295643166.md)
- [Robo.ai COO Chaoyin Xie files initial beneficial ownership statement](https://longbridge.com/en/news/296381712.md)
- [Sino Biopharm declares 2026 interim dividend of HKD 0.07 a share](https://longbridge.com/en/news/296324109.md)
- [China Medical System Revises Interim Dividend for First Half of 2026](https://longbridge.com/en/news/296184471.md)
- [CF PharmTech schedules board meeting to review interim results](https://longbridge.com/en/news/296325404.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**